- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03030339
Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children (GloVitAS-P)
Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children Exposed to Multiple Vitamin A Intervention Programs
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
National Capital Region
-
Mandaluyong, National Capital Region, Philippines
- Block 37 Health Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children 12-18 months of age, and their mothers (18-49 years of age)
- Living in selected communities in the National Capital Region of the Philippines
- The mother and child must plan to stay in the study area for the duration of the study.
- Child's estimated vitamin A intake and exposure to vitamin A programs must meet eligibility criteria for one of three groups, based on a screening questionnaire administered by an interviewer to the child's mother.
Eligibility criteria for children in Group 1: 1) consumed MNP or a multi-vitamin preparation that contains vitamin A in the previous 7 days, 2) consumed at least one fortified staple food (oil or wheat flour) in the previous 7 days, 3) consumed breast milk or fortified milk in the past 24 hours, 4) received a high-dose VA capsule during the previous month, and 5) received a screening tool 'score' suggesting VA intake above 600 µg retinol/d.
Eligibility criteria for children in Group 2: will include children who: 1) consumed MNP or a multi-vitamin A preparation that contains vitamin A in the previous 7 days, 2) consumed at least one fortified staple food (oil or wheat flour) in the previous 7 days, 3) consumed breast milk or fortified milk in the past 24 hours, 4) received a high-dose VA capsule in the previous 3-6 months, and 5) received a screening tool 'score' suggesting VA intake above 600 µg retinol/d.
Eligibility criteria for children in Group 3: will include children who: 1) received a high dose VA capsule during the previous 3-6 months, and 2) received a screening tool 'score' suggesting VA intake 200-500 µg/d.
Exclusion Criteria:
- The child did not receive a high-dose VA capsule during the most recent national campaign
- The mother or child has chronic disease
- The child has moderate or severe anemia (Hb <10 g/dL)
- The mother or child has signs or symptoms of vitamin A deficiency (Bitot's spots, conjunctival xerosis, nightblindness)
- The child has weight for length < -2 z-scores of the median of the WHO growth standards
- The mother is breastfeeding more than one child
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1: High VA intake, recent VAS
Children who are exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement (VAS; 200,000 IU) in the past month, and are identified as being likely to have chronic excessive dietary VA intake
|
Children who are exposed to multiple VA programs, have received a high-dose VA supplement (VAS; 200,000 IU) in the past month, and are identified as being likely to have chronic excessive dietary VA intake.
|
Group 2: High VA intake
Children who are exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement (200,000 IU) in the past 3-6 months, and are identified as being likely to have chronic excessive dietary VA intake.
|
Children who are exposed to multiple VA programs, have received a high-dose VA supplement (200,000 IU) in the past 3-6 months, and are identified as being likely to have chronic excessive dietary VA intake.
|
Group 3: Low/adequate VA intake
Children who are not exposed to multiple vitamin A (VA) programs, have received a high-dose VA supplement in the past 3-6 months, and are identified as being likely to have chronic low to adequate dietary VA intake.
|
Children who are not exposed to multiple VA programs, have received a high-dose VA supplement in the past 3-6 months, and are identified as being likely to have chronic low to adequate dietary VA intake.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total body vitamin A stores among children 12-18 mo of age
Time Frame: 28-day study period
|
Estimated using the 13C-retinol dilution method
|
28-day study period
|
Total dietary vitamin A intake among children 12-18 mo of age
Time Frame: 28-day study period
|
Estimated using 24-hour dietary recalls, observed weighed food records, food and supplement frequency questionnaire, breast milk vitamin A concentration, and total breast milk intake (measured by the dose-to-mother deuterium dilution technique)
|
28-day study period
|
Total breast milk intake (among breastfeeding children 12-18 mo of age)
Time Frame: 15-day study period
|
Estimating using the dose-to-mother deuterium dilution technique.
|
15-day study period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Plasma or serum retinol among children 12-18 mo of age
Time Frame: 28-day study period
|
28-day study period
|
|
Plasma or serum retinol-binding protein among children 12-18 mo of age
Time Frame: 28-day study period
|
28-day study period
|
|
Ratio of retinol to retinol-binding protein among children 12-18 mo of age
Time Frame: 28-day study period
|
28-day study period
|
|
Retinol metabolites among children 12-18 mo of age
Time Frame: 28-day study period
|
28-day study period
|
|
Transthyretin among children 12-18 mo of age
Time Frame: 28-day study period
|
28-day study period
|
|
Bone health markers among children 12-18 mo of age
Time Frame: 28-day study period
|
28-day study period
|
|
Liver function markers among children 12-18 mo of age
Time Frame: 28-day study period
|
28-day study period
|
|
Consumption of fortifiable foods among women
Time Frame: 28 day study period
|
Estimated by combining data from 24-hour recalls, observed weighed food records, food frequency questionnaires, and the Fortification Assessment Coverage Tool
|
28 day study period
|
Consumption of fortifiable foods among children
Time Frame: 28 day study period
|
Estimated by combining data from 24-hour recalls, observed weighed food records, food frequency questionnaires, and the Fortification Assessment Coverage Tool
|
28 day study period
|
Total vitamin A intake among women
Time Frame: 28-day study period
|
Estimated using 24-hour dietary recalls and food frequency questionnaires
|
28-day study period
|
Breast milk vitamin A concentration among lactating women
Time Frame: 28-day study period
|
28-day study period
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total food and nutrient intakes among women
Time Frame: 28-day study period and 30 days prior to study period
|
28-day study period and 30 days prior to study period
|
Total food and nutrient intakes among children
Time Frame: 28-day study period and 30 days prior to study period
|
28-day study period and 30 days prior to study period
|
Infant weight-for-length z score
Time Frame: At recruitment
|
At recruitment
|
Infant length-for-age z score
Time Frame: At recruitment
|
At recruitment
|
Systemic inflammation among children
Time Frame: 28-day study period
|
28-day study period
|
Iron status among children
Time Frame: 28-day study period
|
28-day study period
|
Zinc status among children
Time Frame: 28-day study period
|
28-day study period
|
Hepatitis infection among children
Time Frame: 28-day study period
|
28-day study period
|
Genetic markers related to vitamin A metabolism among children
Time Frame: 28-day study period
|
28-day study period
|
Infant hemoglobin concentration
Time Frame: At enrollment
|
At enrollment
|
Infant morbidity symptoms
Time Frame: 28-day study period and previous 7 days
|
28-day study period and previous 7 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Georg Lietz, Newcastle University
Publications and helpful links
General Publications
- Engle-Stone R, Miller JC, Reario MFD, Arnold CD, Stormer A, Lafuente E, Oxley A, Capanzana MV, Cabanilla CVD, Ford JL, Clark A, Velavan TP, Brown KH, Lietz G, Haskell MJ. Filipino Children with High Usual Vitamin A Intakes and Exposure to Multiple Sources of Vitamin A Have Elevated Total Body Stores of Vitamin A But Do Not Show Clear Evidence of Vitamin A Toxicity. Curr Dev Nutr. 2022 Jul 25;6(8):nzac115. doi: 10.1093/cdn/nzac115. eCollection 2022 Aug.
- Oxley A, Engle-Stone R, Miller JC, Reario MFD, Stormer A, Capanzana MV, Cabanilla CVD, Haskell MJ, Lietz G. Determination of Vitamin A Total Body Stores in Children from Dried Serum Spots: Application in a Low- and Middle-Income Country Community Setting. J Nutr. 2021 May 11;151(5):1341-1346. doi: 10.1093/jn/nxaa446.
- Ford JL, Green JB, Haskell MJ, Ahmad SM, Mazariegos Cordero DI, Oxley A, Engle-Stone R, Lietz G, Green MH. Use of Model-Based Compartmental Analysis and a Super-Child Design to Study Whole-Body Retinol Kinetics and Vitamin A Total Body Stores in Children from 3 Lower-Income Countries. J Nutr. 2020 Feb 1;150(2):411-418. doi: 10.1093/jn/nxz225.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 903681
- OPP1115464 (Other Grant/Funding Number: Other)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin A Status
-
Institute of Nutrition of Central America and PanamaBill and Melinda Gates Foundation; Newcastle University; International Atomic...Completed
-
Prince of Songkla UniversityUnknown
-
University of California, DavisHelen Keller InternationalCompleted
-
Tufts UniversityNutricia Research Fundation; National University of Science and Technology,...Completed
-
University of Wisconsin, MadisonCompletedVitamin A Status With Maize Feeding
-
North-West University, South AfricaMedical Research Council, South Africa; National Research Foundation of South... and other collaboratorsCompletedMalnutrition | Vitamin A Status | Iron Status | Zinc StatusSouth Africa
-
National Food Technology Research Centre, BotswanaNetherlands: Ministry of Health, Welfare and Sports; UNICEF; University of BotswanaUnknownAssessment of Vitamin A Status of Children
-
University of UlsterNorthern Ireland Executive; HSC Public Health AgencyCompletedVitamin D Status | Vitamin D ConcentrationUnited Kingdom
-
University of CopenhagenCompleted
-
Sheffield Children's NHS Foundation TrustCompleted
Clinical Trials on High VA intake, recent VAS
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
University of AarhusAarhus University Hospital; University of East Anglia; Kolding SygehusCompleted
-
Texas State UniversityRecruitingEndothelial Dysfunction | Sodium IntakeUnited States
-
Medical University of ViennaCompleted
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompletedAutosomal Dominant Polycystic KidneyUnited States
-
Carmine ZoccaliCompletedEssential Hypertension.
-
University of California, San DiegoRecruiting
-
University of LausanneUniversity Hospital Inselspital, BerneCompleted
-
University of Sao PauloUnknownCancer | Surgery | Critically IllBrazil
-
University of CopenhagenDairy Farmers of Canada; The Danish Dairy Research Foundation, Denmark; Dairy... and other collaboratorsCompleted